Smell, or olfaction, is mediated by the olfactory system, which includes the olfactory pithelium in the nasal cavity and the olfactory bulb in the brain. Odor molecules enter the nasal cavity, where they bind to olfactory receptor neurons in the olfactory epithelium, triggering electrical signals transmitted to the olfactory bulb and then to higher brain regions for processing.
Disorders affecting smell include:
Research suggests potential links between olfactory dysfunction and metabolic disorders like insulin resistance and diabetes. Chronic hyperglycemia and microvascular complications associated with diabetes may contribute to olfactory nerve damage and impaired olfactory function.
Obesity-related conditions like obstructive sleep apnea and nasal congestion can impair the sense of smell. Additionally, obesity-related inflammation may affect olfactory receptors and neural pathways involved in smell perception.
Diabetes-related neuropathy can affect the olfactory nerve, leading to anosmia (loss of smell) or hyposmia (reduced ability to smell). Changes in smell perception may impact appetite and food enjoyment in individuals with diabetes.
Anosmia refers to the complete loss of the sense of smell. It can result from various causes, including nasal congestion, head trauma, neurological disorders, or viral infections such as the common old. While metabolic factors are not typically directly implicated in anosmia, conditions associated with hyperinsulinemia, insulin resistance, or metabolic syndrome, such as diabetes mellitus, may increase the risk of nerve damage or vascular changes affecting olfactory function. Chronic hyperglycemia and oxidative stress associated with diabetes can impair nerve function, potentially contributing to anosmia.
" Over 24% of older American adults (approximately 14 million) are estimated to have reduced olfactory sensitivity. Previous studies have provided evidence that patients with diabetes mellitus (DM) or its complications are at increased risk of olfactory dysfunction. We therefore investigated whether smell dysfunction was associated with DM-related biomarkers, including fasting blood glucose, glycohemoglobin, serum insulin, and homeostasis model assessment of insulin sensitivity (HOMA-IR), in older US adults."
"We found a significant association between smell dysfunction and severe insulin resistance in older US adults. Our data suggests that insulin resistance may be mechanistically linked to loss of smell function"
Hyposmia refers to a reduced sense of smell, where individuals may have difficulty detecting or distinguishing odors. It can be caused by various factors, including nasal congestion, nasal polyps, aging, or neurological conditions.
Metabolic syndrome-associated conditions, such as obesity or diabetes mellitus, may indirectly affect olfactory function through alterations in nasal airflow or inflammatory responses in the nasal passages. Insulin resistance and hyperinsulinemia may exacerbate inflammation or vascular changes in the nasal mucosa, potentially contributing to hyposmia.
" The prevalence of olfactory dysfunction was significantly higher in older people with MetS than in those without MetS in both sexes "
" Results of this pilot study shed light on the link between cerebral insulin level and an impaired sense of smell. This research line might provide a better understanding of olfactory loss in relation to eating and dietary behavior, and could offer opportunities to develop faster therapeutic intervention for patients with olfactory dysfunction "
" We have provided evidence of an association between lowered insulin sensitivity ..... and deteriorated olfactory function. "
"Nowadays, it is well accepted that obesity and metabolic syndrome are diseases that constitute a global public health issue. In consequence, the interest in the study of the effects these pathologies produce in the central nervous system has greatly increased in the last decades. One of the most overlooked topics in the literature is the impact they exert in sensory systems, among which is olfaction. The olfactory system is related to a number of vital functions, like the activation of defense mechanisms, contribution to appetitive and digestive reflexes, recognition of conspecifics, and even has socio-sexual implications. It has been discovered that the olfactory system also plays a crucial role in food intake, the choice of foods, appetite and satiety mechanisms; therefore, it is involved in obesity development. Clinical studies have proven that obese patients exhibit hyposmia more frequently than aged-matched healthy controls. Olfactory alterations have also been found in obese rodents or in animals with similar features of human metabolic syndrome. The causes of this association are still being investigated. This work reviews the studies that have tried to understand this association from a preclinical and clinical approach as well as those biological mechanisms that could be involved. The evidences here presented suggest that obesity and metabolic syndrome affect the adequate function of olfactory sensory system. "
Parosmia is a condition where individuals perceive smells differently from how they actually are. Common triggers include viral infections, head trauma, or nasal irritation.
While the exact mechanisms of parosmia are not fully understood, metabolic factors such as insulin resistance and hyperinsulinemia may contribute to alterations in olfactory processing or neuronal signaling, potentially leading to distorted perceptions of smell. Metabolic syndrome-associated conditions, such as diabetes mellitus, may exacerbate nerve damage or inflammation in the olfactory pathways, further influencing parosmia symptoms.
" Results of this pilot study shed light on the link between cerebral insulin level and an impaired sense of smell. This research line might provide a better understanding of olfactory loss in relation to eating and dietary behavior, and could offer opportunities to develop faster therapeutic intervention for patients with olfactory dysfunction "
Phantosmia involves perceiving smells that are not actually present. It can be associated with conditions such as migraines, seizures, or neurological disorders.
Metabolic factors such as insulin resistance and hyperinsulinemia may indirectly affect phantosmia through alterations in neuronal activity or neurotransmitter function in the olfactory pathways. Conditions associated with metabolic syndrome, such as hypertension or dyslipidemia, may also affect blood flow to the olfactory regions of the brain, potentially influencing phantosmia symptoms.
Presbyosmia is a term used to describe age-related changes in the sense of smell. It refers to the gradual decline in the ability to detect and differentiate odors that occurs with advancing age. Like other sensory systems, the sense of smell can be affected by aging, leading to decreased sensitivity to odors and changes in olfactory perception.
Several factors contribute to presbyosmia, including:
Loss of Olfactory Receptor Cells: With age, there is a natural decline in the number of olfactory receptor cells in the nasal epithelium. These cells are responsible for detecting odor molecules in the air. A reduction in the number of receptor cells can lead to decreased sensitivity to odors.
Changes in Olfactory Bulb and Brain Function:Age-related changes in the olfactory bulb, which is part of the brain responsible for processing olfactory information, can also contribute to presbyosmia. Additionally, alterations in higher brain regions involved in olfactory processing may affect the perception and interpretation of odors.
Decreased Mucous Secretion: Aging may lead to reduced mucous secretion in the nasal passages, which can affect the ability of odor molecules to dissolve and bind to olfactory receptors. This can further contribute to diminished olfactory sensitivity.
Degeneration of Olfactory Nerves: The olfactory nerves, which transmit signals from the olfactory receptor cells to the brain, may undergo degenerative changes with age. This can impair the transmission of olfactory information and reduce the ability to perceive odors.
Presbyosmia can have various effects on individuals, including:
Insulin resistance, hyperinsulinemia, and metabolic syndrome can potentially affect presbyosmia through several mechanisms:
Olfactory Receptor Cell Function:
Insulin resistance and hyperinsulinemia may impair cellular function and signaling pathways in olfactory receptor cells, potentially reducing their sensitivity to odor molecules. This can contribute to diminished olfactory perception and presbyosmia.
Olfactory Bulb and Brain Function:
Insulin resistance and metabolic syndrome-related factors such as inflammation and oxidative stress may affect the structure and function of the olfactory bulb and higher brain regions involved in olfactory processing. This can lead to alterations in olfactory perception and interpretation, contributing to presbyosmia.
Mucous Secretion:
Insulin resistance and metabolic syndrome may influence mucous secretion in the nasal passages through various mechanisms, including chronic inflammation and changes in hormonal regulation. Reduced mucous secretion can impair the ability of odor molecules to dissolve and bind to olfactory receptors, exacerbating presbyosmia.
Olfactory Nerve Integrity:
Insulin resistance and hyperinsulinemia can contribute to vascular dysfunction and microvascular disease, which may affect the integrity of the olfactory nerves. Degenerative changes in olfactory nerve fibers can impair the transmission of olfactory signals to the brain, further contributing to presbyosmia.
Overall, the effects of insulin resistance, hyperinsulinemia, and metabolic syndrome on presbyosmia are complex and multifactorial. These metabolic disturbances can impact various aspects of olfactory function, including receptor cell sensitivity, neural processing, mucous secretion, and nerve integrity, potentially exacerbating age-related declines in olfactory perception. However, further research is needed to fully understand the specific mechanisms underlying the relationship between metabolic disorders and presbyosmia.
" We have provided evidence of an association between lowered insulin sensitivity ..... and deteriorated olfactory function. "
" Olfactory dysfunction and tinnitus are age-related otorhinolaryngological disorders with a high prevalence in the elderly population and share several common clinical features. However, there is no study investigating the relationship between these two diseases. We studied the prevalence of olfactory dysfunction and tinnitus among Koreans and studied the relationship between these two diseases based on the Korean National Health and Nutrition Examination Survey. The subjects of this study were enrolled from the Fifth Korean National Health and Nutrition Examination Survey (2010-2012, n = 25,534). Data of subjects aged 40 years and older who underwent physical examination and completed a self-reported questionnaire and other anthropometric variables were statistically analyzed. Odds ratios were calculated to identify the relationship between olfactory dysfunction and tinnitus, using multiple logistic regression models. Older males, non-smokers, non/lower alcohol drinker groups exhibited the relationship between olfactory dysfunction and tinnitus. Metabolic syndrome and mental health problems were associated with both olfactory dysfunction and tinnitus. After adjusting for confounding factors, olfactory dysfunction was significantly associated with tinnitus (OR 1.318). There was a dose-response relationship between tinnitus severity and the odds of olfactory dysfunction (ORs for mild, moderate and severe tinnitus were, respectively, 1.134, 1.569 and 2.044). Additional molecular genetics and animal studies are needed to determine the shared pathophysiology of the two diseases. "
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Copyright © 2024 Metabolic Health Malta - All Rights Reserved.
metabolichealthmalta.com
disclaimer The views and opinions expressed on this site are solely those of the contributing individuals and authors, and in no way reflect or represent the position of the authors' employers, management, shareholders or other employees thereof. All data and information provided on this site is for informational purposes only. We make no representations as to accuracy, completeness, currentness, suitability, or validity of any information on this site and will not be liable for any errors, omissions, or delays in this information or any losses, injuries, or damages arising from its display or use. All information is provided on an as-is basis.
We do not provide medical advice. All individuals should seek personal medical assistance in considering adopting any personal diet. No responsibility can be taken for any actions taken by anyone including health professionals, social media or personal health.
Powered by GoDaddy